Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Tomlin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drug Safety|August 7, 2012
Methods for retrospective detection of drug safety signals and adverse events in electronic general practice recordsAndrew Tomlin, David Reith, Susan Dovey, et al.
The New Zealand Medical Journal|June 6, 2006
Health status of New Zealand European, Maori, and Pacific patients with diabetes at 242 New Zealand general practicesAndrew Tomlin, Murray Tilyard, Alexander Dawson, et al.
The New Zealand Medical Journal|July 20, 2020
Reduced community antibiotic dispensing in New Zealand during 2015-2018: marked variation in relation to primary health organisationMark Thomas, Andrew Tomlin, Eamon Duffy, et al.
Epilepsia|January 26, 2020
Mortality and morbidity of patients with treated and untreated epilepsy in New ZealandKristen Joy Hamilton, Zhibin Chen, Andrew Tomlin, et al.
Respiratory Medicine|July 22, 2023
Asthma exacerbations in New Zealand 2010-2019: A national population-based studyAmy Hai Yan Chan, Andrew Tomlin, Kebede Beyene, et al.
Age and Ageing|September 2, 2023
Predictors of persistent opioid use in non-cancer older adults: a retrospective cohort studyKebede Beyene, Hoda Fahmy, Amy Hai Yan Chan, et al.
Australasian Journal on Ageing|January 20, 2024
Patterns of opioid use in New Zealand older adults, 2007-2018Hoda Fahmy, Amy Hai Yan Chan, Gary Cheung, et al.
Nephrology (Carlton, Vic.)|May 3, 2018
Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New ZealandHywel Lloyd, Grace Li, Andrew Tomlin, et al.
Pharmacoepidemiology and Drug Safety|June 2, 2020
Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort studyAndrew Tomlin, David John Woods, Angela Lambie, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysisAmy Hai Yan Chan, Andrew Tomlin, Eliza Chan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drug Safety|August 7, 2012
Methods for retrospective detection of drug safety signals and adverse events in electronic general practice recordsAndrew Tomlin, David Reith, Susan Dovey, et al.
The New Zealand Medical Journal|June 6, 2006
Health status of New Zealand European, Maori, and Pacific patients with diabetes at 242 New Zealand general practicesAndrew Tomlin, Murray Tilyard, Alexander Dawson, et al.
The New Zealand Medical Journal|July 20, 2020
Reduced community antibiotic dispensing in New Zealand during 2015-2018: marked variation in relation to primary health organisationMark Thomas, Andrew Tomlin, Eamon Duffy, et al.
Epilepsia|January 26, 2020
Mortality and morbidity of patients with treated and untreated epilepsy in New ZealandKristen Joy Hamilton, Zhibin Chen, Andrew Tomlin, et al.
Respiratory Medicine|July 22, 2023
Asthma exacerbations in New Zealand 2010-2019: A national population-based studyAmy Hai Yan Chan, Andrew Tomlin, Kebede Beyene, et al.
Age and Ageing|September 2, 2023
Predictors of persistent opioid use in non-cancer older adults: a retrospective cohort studyKebede Beyene, Hoda Fahmy, Amy Hai Yan Chan, et al.
Australasian Journal on Ageing|January 20, 2024
Patterns of opioid use in New Zealand older adults, 2007-2018Hoda Fahmy, Amy Hai Yan Chan, Gary Cheung, et al.
Nephrology (Carlton, Vic.)|May 3, 2018
Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New ZealandHywel Lloyd, Grace Li, Andrew Tomlin, et al.
Pharmacoepidemiology and Drug Safety|June 2, 2020
Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort studyAndrew Tomlin, David John Woods, Angela Lambie, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysisAmy Hai Yan Chan, Andrew Tomlin, Eliza Chan, et al.
Pageof 3